A COMPOUND FOR PREVENTING AND DEODORIZING UNPLEASANT ODOUR OF HUMAN EXCRETION,RECOMMENDED FOR PATIENTS AFTER ILEOSTOMY AND COLOSTOMY AND SIMILAR USE

• 1. 包含基于萘醌的化合物作为活性成分的用于预防或改善作为与抗癌药物治疗相关的副作用的疲劳、恶病质、疼痛、认知衰退和造血干细胞减少的组合物 [P] . 中国专利： CN109414427A . 2019-03-01
• 2. 用于治疗、延缓和/或预防人类遗传性疾病如强直性肌营养不良症1型（DM1）的化合物 [P] . 中国专利： CN103747805B . 2017.08.29
• 3. A URINARY SYSTEM MAKING THE INVOLUNTARY EXCRETION OCCURING AFTER COLOSTOMY, ILEOSTOMY AND UROSTOMY VOLUNTARY [P] . WO2021188061A1 . 2021-09-23

  机译： 一个泌尿系统，使不自主排泄在Colostomy，oleoStomy和口疮自愿性发生后发生的

• 4. Neutralizing agent, the odours unpleasant of the animal excretions and excrement. [P] . 法国专利： FR2599257B1 . 1989-12-29

  机译： 中和剂，使动物排泄物和排泄物产生难闻的气味。

• 5. A SAFE AND IMPROVED OSTOMY DEVICE ADAPTABLE TO PATIENTS HAVING COLOSTOMY OR ILEOSTOMY [P] . IN2009KO01409A . 2012-10-19

  机译： 适用于患有结肠切除或回肠切除术的患者的安全且改良的渗透压设备

• 1. Human metabolism of the biocidal compounds methylisothiazolinone and chloromethylisothiazolinone: excretion kinetics of N-methylmalonamic acid in urine [C] . Thomas Schettgen, Jens Bertram, Thomas Kraus Annual conference of the International Society of Exposure Science . 2016
• 2. THE ABSORPTION AND EXCRETION OF CALCIUM AND PHOSPHORUS IN THREE PATIENTS WITH COLOSTOMY AND ILEOSTOMY [O] . Richard M. Johnson 1937
• 3. THE ABSORPTION AND EXCRETION OF CALCIUM AND PHOSPHORUS IN THREE PATIENTS WITH COLOSTOMY AND ILEOSTOMY [O] . Johnson, Richard M. 1937
• 4. Recommended Toxicity Equivalence Factors (TEFs) for Human Health Risk Assessments of 2,3,7,8-Tetrachlorodibenzo-p- Dioxin and Dioxin-Like Compounds [R] . 2010

• 1. ATG用于预防异基因造血干细胞移植后GVHD的Meta分析 [A] . 李孝杰 . 2017